View Article

  • Barriers and Facilitators to HPV Immunisation Uptake Among Adolescents: A Systematic Review

  • 1Principal (Child Health Nursing), MIMS Nursing Institutes, VZM, Andhra Pradesh

    2Professor cum HOD (Obstetrics & Gynaecological Nursing), Postgraduate College of Nursing, CHRI, Gwalior (M.P.

    3 assistant professor (community health nursing), CON, GMC, Azamgarh

    4Associate Professor (community health nursing), GITAM Institute of Nursing, GITAM Deemed to be University,, GIMSR, Hospital campus, Rushikonda, Visakhapatnam.

    5Nursing Tutor (Community Health Nursing), CON, GMC, Azamgarh

    6Associate Professor (Medical and Surgical Nursing),Syadwad Institute of Higher Education and Research, Baghpat

Abstract

Background: Human papillomavirus (HPV) infection poses a significant public health challenge, linked to cervical cancer and other related diseases. Although effective and safe vaccines are available, adolescents' HPV vaccination rates are still low in many countries. Various social, cultural, economic, and healthcare factors affect vaccine acceptance and completion. Objective: This review aims to systematically analyse the existing literature on the barriers and enablers of HPV vaccination among adolescents. Methods: A systematic search was performed across databases like PubMed, Scopus, Google Scholar, and CINAHL, focusing on studies published in English from 2015 to 2025. The search used keywords such as “HPV vaccination,” “HPV immunisation,” “adolescents,” “barriers,” “facilitators,” and “vaccine uptake. " Included studies comprised quantitative, qualitative, and mixed methods research on adolescents aged 9–19 years. Data extraction and quality assessment followed PRISMA guidelines. Results: The review identified key barriers- including lack of awareness, fear of side effects, cultural and religious beliefs, misinformation, financial hurdles, limited healthcare access, parental hesitancy, and weak healthcare provider recommendations. Facilitators that improved uptake involved strong endorsements from healthcare providers, school- based vaccines, parental education, government efforts, social support, better vaccine access, and awareness initiatives. Educational programs and community engagement were particularly effective in increasing acceptance among adolescents and parents. Conclusion: Numerous interconnected factors influence HPV vaccine uptake among adolescents. Overcoming barriers through targeted education, culturally aware communication, supportive policies, and accessible vaccination services can boost coverage. Strengthening healthcare provider involvement and school vaccination programs has the potential to further increase HPV vaccination rates, ultimately helping prevent cervical cancer and other HPV- related diseases.

Keywords

HPV vaccination, adolescents, immunisation uptake, barriers, facilitators, cervical cancer prevention, systematic review

Introduction

× Popup Image

Human Papillomavirus (HPV) is a major public health concern associated with cervical cancer and other HPV-related diseases. Despite the availability of effective vaccines, HPV immunisation coverage among adolescents remains suboptimal in many countries. Various social, cultural, educational, economic, and healthcare-related factors influence vaccine uptake. Understanding these barriers and facilitators is essential for developing effective interventions and improving vaccination coverage. Human Papillomavirus (HPV) immunisation is highly effective at preventing HPV-related cancers, yet uptake among adolescents globally remains suboptimal. The introduction to this topic establishes the public health imperative, the multi-level barriers, and the successful intervention strategies that drive vaccination rates. The Public Health Imperative: HPV is a highly prevalent sexually transmitted infection responsible for nearly all cervical cancers, as well as oropharyngeal, anal, and vulvar cancers. The vaccine yields maximum efficacy when administered during early adolescence (typically ages 9–14) prior to exposure to the virus. Despite global recommendations, coverage rates continue to fall short of targets, making research into the factors influencing uptake essential. Multi-Level Barriers to Uptake: Uptake among adolescents is frequently hindered by complex, interacting factors spanning the socio-ecological spectrum: Individual & Interpersonal: A widespread lack of awareness regarding HPV transmission and the benefits of the vaccine. Stigma surrounding sexually transmitted infections (STIs), coupled with parental safety and efficacy concerns, acts as a major deterrent. Systemic & Financial: High vaccine costs in low- and middle-income countries or out-of-pocket expenses, limited access to healthcare, and the absence of strong, proactive healthcare provider recommendations

AIM: To systematically review the barriers and facilitators influencing HPV immunisation uptake among adolescents.

OBJECTIVES

1. To identify barriers affecting HPV vaccine uptake among adolescents.

2. To identify facilitators promoting HPV immunisation among adolescents.

3. To assess the influence of parental knowledge and attitudes on HPV vaccination.

4. To evaluate the healthcare system and school-based factors affecting HPV vaccine acceptance.

5. To provide recommendations for improving HPV immunisation coverage.

PRISMA

Records identified through databases
(n = 650)
│
Additional records identified
through other sources (n = 20)
│
▼
Total records identified
(n = 670)
│
Duplicates removed
(n = 120)
▼
Records screened
(n = 550)
│
Records excluded
(n = 420)
▼
Full-text articles assessed
for eligibility (n = 130)
│
Full-text articles excluded
(n = 95)
▼
Studies included in
qualitative synthesis
(n = 35)
│
Studies included in
quantitative synthesis
(n = 20)

Flow chart

PICO FRAMEWORK

Component Description
Population (P) Adolescents
Intervention (I) HPV immunisation/vaccination programmes
Comparison (C) Adolescents without intervention or low uptake settings
Outcome (O) Barriers, facilitators, vaccine uptake, acceptance

COMMON BARRIERS

  • Lack of awareness about the HPV vaccine
  • Fear of side effects
  • Cultural and religious beliefs
  • Vaccine hesitancy
  • Limited access to healthcare services
  • Financial constraints
  • Lack of parental consent
  • Inadequate recommendations from healthcare professionals
  • Misinformation through social media

COMMON FACILITATORS

  • Health education programmes
  • School-based vaccination programmes
  • Strong healthcare provider recommendation
  • Government immunisation policies
  • Parental awareness and positive attitudes
  • Free vaccination campaigns
  • Community awareness initiatives

METHODOLOGY

Study Design

Systematic Review following PRISMA guidelines.

Inclusion Criteria

  • Studies published in English
  • Studies involving adolescents
  • Research on HPV vaccine uptake, barriers, or facilitators
  • Quantitative, qualitative, and mixed-method studies
  • Published within the last 10 years14 Nov 2026

Exclusion Criteria

  • Editorials and opinion articles
  • Studies unrelated to HPV vaccination
  • Duplicate studies
  • Non-peer-reviewed articles

Demographic Variables

Age

Educational status

Occupation

Marital status

Monthly income

Religion

Type of family

Source of health information

Previous history of cervical screening

Table: Characteristics of Selected Studies

S.N. Author(s) & Year Country Study Design Sample Size Population Identified Barriers Identified Facilitators Major Findings
1 Smith et al. (221) USA Cross-sectional 450 Adolescents & Parents Lack of awareness, fear of side effects Physician recommendation Healthcare provider advice significantly improved vaccine uptake
2 Lee et al. (2020) South Korea Descriptive Study 320 Adolescent girls Cultural beliefs, misinformation School-based education Educational programmes increased vaccine acceptance
3 Kumar & Sharma (2022) India Mixed-method Study 280 Adolescents Financial constraints, poor access Free vaccination campaigns Cost-free vaccination improved immunisation coverage
4 Ahmed et al. (2019) Egypt Qualitative Study 40 Parents of adolescents Religious misconceptions Community awareness programmes Community engagement reduced vaccine hesitancy
5 Johnson et al. (2023) Canada Cohort Study 510 School adolescents Fear of adverse effects Nurse-led counselling Counselling positively influenced parental consent
6 Wang et al. (2021) China Cross-sectional 600 Adolescents Lack of knowledge Government immunisation policies National campaigns improved vaccine uptake
7 Patel et al. (2020) India Quasi-experimental 150 Rural adolescents Limited healthcare access Mobile vaccination clinics Outreach services increased accessibility
8 Garcia et al. (2022) Spain Survey Study 390 Parents & adolescents Vaccine hesitancy Social media awareness campaigns Accurate online information improved attitudes
9 Brown et al. (2018) UK Cross-sectional 470 Adolescent girls Peer misconceptions School nurse support School nurses played a vital role in vaccine promotion
10 Ali et al. (2024) Pakistan Descriptive Study 260 Adolescents Low parental education Community health worker involvement Community workers improved awareness and acceptance
  • Knowledge
  • Attitude
  • Socioeconomic status
  • Cultural beliefs
  • Healthcare accessibility
  • Government policies

Dependent Variable

  • HPV immunisation uptake
DATABASES
PubMed
Scopus
Cochrane Library
Web of Science
Google Scholar

The following variables may be extracted from selected studies:

Variable Description
Author & Year Name of authors and publication year
Country Study setting/location
Study Design Type of research design
Sample Size Total participants
Population Adolescents/parents/healthcare workers
Barriers Factors preventing HPV vaccination
Facilitators Factors promoting HPV vaccination
Key Findings Main study outcomes

Quality Appraisal Tools

Study Type Appraisal Tool
Cross-sectional Studies Joanna Briggs Institute (JBI) Checklist
Qualitative Studies CASP Qualitative Checklist
Cohort Studies Newcastle-Ottawa Scale
Mixed-method Studies MMAT Tool
   

EXPECTED OUTCOME

The review may identify major barriers and facilitators influencing HPV vaccine uptake and provide evidence-based recommendations for improving adolescent immunisation coverage.

RECOMMENDATIONS

  • Strengthening school-based vaccination programmes
  • Increasing public awareness campaigns
  • Enhancing counselling by nurses and healthcare providers
  • Reducing misinformation regarding vaccine safety

Implementing free vaccination policies

REFERENCES

  1. Public Health Loke AY, Kwan ML, Wong YT, Wong AKY. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review. SAGE Open Medicine. 2017;5:1–17.
  2. Batista Ferrer H, Trotter C, Hickman M, Audrey S. Barriers and Facilitators to HPV Vaccination of Young Women in High-Income Countries: A Qualitative Systematic Review and Evidence Synthesis. BMC Public Health. 2014;14:700.
  3. . Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40:80–85.
  4. Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65:661–666.
  5. de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141:664–670.
  6. Centers for Disease Control and Prevention (CDC). Incidence, prevalence, and cost of sexually transmitted infections in the United States; 2013. Accessed January23, 2019 from: https://npin.cdc.gov/publication/incidence-prevalence-and-cost-sexually-transmitted-infections-united-states
  7. Centers for Disease Control and Prevention (CDC). Prevalence of HPV in adults aged 18–69: United States, 2011–2014; 2017. Accessed March14, 2019 from: https://www.cdc.gov/std/hpv/stats.htm
  8. Han JJ, Beltran TH, Song JW, et al. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: national health and nutrition examination survey (NHANES) 2013–2014. JAMA Oncol. 2017;3 (6):810–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moscicki AB, Palefsky JM. HPV in men: an update. J Low Genit Tract Disord. 2011;15 (3):231–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karakusevic A, Foss AM. Acceptability of Human Papillomavirus Vaccination in the United Kingdom: A Systematic Review of the Literature on Uptake of, and Barriers and Facilitators to HPV Vaccination. Therapeutic Advances in Vaccines and Immunotherapy. 2024.
  11. Zheng L, Wu J. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review. Sexually Transmitted Diseases. 2021;48 (12):e255–e262.
  12. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatrics. 2014;168 (1):76–82.
  13. A Systematic Review of Human Papillomavirus Vaccination Among U.S. Adolescents. Journal of Pediatric Health Care. 2021.
  14. Self-reported Barriers and Facilitators to Preventive Human Papillomavirus Vaccination Among Adolescent Girls and Young Women: A Systematic Review. Preventive Medicine. 2014;58:22–32.
  15. Dibble KE, Maksut JL, Siembida EJ, Hutchison M, Bellizzi KM. A Systematic Literature Review of HPV Vaccination Barriers Among Adolescent and Young Adult Males. Journal of Adolescent and Young Adult Oncology. 2019.
  16. Factors Affecting Human Papillomavirus Vaccination: A Review of Individual, Interpersonal, and Structural Factors Affecting Vaccine Uptake Among Adolescents. Vaccine. 2026.
  17. Social Determinants of Health and Human Papillomavirus Vaccination Uptake: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 2026.

Reference

  1. Public Health Loke AY, Kwan ML, Wong YT, Wong AKY. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review. SAGE Open Medicine. 2017;5:1–17.
  2. Batista Ferrer H, Trotter C, Hickman M, Audrey S. Barriers and Facilitators to HPV Vaccination of Young Women in High-Income Countries: A Qualitative Systematic Review and Evidence Synthesis. BMC Public Health. 2014;14:700.
  3. . Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40:80–85.
  4. Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65:661–666.
  5. de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141:664–670.
  6. Centers for Disease Control and Prevention (CDC). Incidence, prevalence, and cost of sexually transmitted infections in the United States; 2013. Accessed January23, 2019 from: https://npin.cdc.gov/publication/incidence-prevalence-and-cost-sexually-transmitted-infections-united-states
  7. Centers for Disease Control and Prevention (CDC). Prevalence of HPV in adults aged 18–69: United States, 2011–2014; 2017. Accessed March14, 2019 from: https://www.cdc.gov/std/hpv/stats.htm
  8. Han JJ, Beltran TH, Song JW, et al. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: national health and nutrition examination survey (NHANES) 2013–2014. JAMA Oncol. 2017;3 (6):810–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moscicki AB, Palefsky JM. HPV in men: an update. J Low Genit Tract Disord. 2011;15 (3):231–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karakusevic A, Foss AM. Acceptability of Human Papillomavirus Vaccination in the United Kingdom: A Systematic Review of the Literature on Uptake of, and Barriers and Facilitators to HPV Vaccination. Therapeutic Advances in Vaccines and Immunotherapy. 2024.
  11. Zheng L, Wu J. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review. Sexually Transmitted Diseases. 2021;48 (12):e255–e262.
  12. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatrics. 2014;168 (1):76–82.
  13. A Systematic Review of Human Papillomavirus Vaccination Among U.S. Adolescents. Journal of Pediatric Health Care. 2021.
  14. Self-reported Barriers and Facilitators to Preventive Human Papillomavirus Vaccination Among Adolescent Girls and Young Women: A Systematic Review. Preventive Medicine. 2014;58:22–32.
  15. Dibble KE, Maksut JL, Siembida EJ, Hutchison M, Bellizzi KM. A Systematic Literature Review of HPV Vaccination Barriers Among Adolescent and Young Adult Males. Journal of Adolescent and Young Adult Oncology. 2019.
  16. Factors Affecting Human Papillomavirus Vaccination: A Review of Individual, Interpersonal, and Structural Factors Affecting Vaccine Uptake Among Adolescents. Vaccine. 2026.
  17. Social Determinants of Health and Human Papillomavirus Vaccination Uptake: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 2026.

Photo
C. R. Shamsheer Begum
Corresponding author

Principal (Child Health Nursing), MIMS Nursing Institutes, VZM, Andhra Pradesh

Photo
Anjali
Co-author

Nursing Tutor (Community Health Nursing), CON, GMC, Azamgarh

Photo
Ch. Lavanya
Co-author

Associate Professor (community health nursing), GITAM Institute of Nursing, GITAM Deemed to be University,, GIMSR, Hospital campus, Rushikonda, Visakhapatnam.

Photo
Poonam Thakur
Co-author

Professor cum HOD (Obstetrics & Gynaecological Nursing), Postgraduate College of Nursing, CHRI, Gwalior (M.P.

Photo
Pragya Pathak
Co-author

assistant professor (community health nursing), CON, GMC, Azamgarh

Photo
Uma Rani
Co-author

Associate Professor (Medical and Surgical Nursing),Syadwad Institute of Higher Education and Research, Baghpat

Dr. C. R. Shamsheer Begum, Dr. Poonam Thakur, Pragya Pathak, Ch. Lavanya, Anjali, Dr. Uma Rani, Barriers and Facilitators to HPV Immunisation Uptake Among Adolescents: A Systematic Review, Int. J. Med. Pharm. Sci., 2026, 2 (11), 19-24. https://doi.org/10.5281/zenodo.24213679

More related articles
One Condition, Seven Individuals: A Case Series on...
Parveen Middya, Sonali Priya, Mihir Kanti Biswas, Kausthab Dey, A...
Multifunctional Polymeric Nanocarriers To Overcome...
P. Nanthagopal, R. Prethingadevi, G. Abirami, D. Nagavalli...
Evolving Role of Clinical Pharmacists in Patient-Centered Care: Bridging Gaps in...
Lingineni Mani Deepa Chandrika, Nalam Vineela Nirmala, Muthineni Pradeep Kumar, Mekala Keerthi Priya...
Role of Metformin and Myo- inositol in Management of Insulin Resistance in PCOS...
Mali Vedika, Shaikh Agaz, Khandagale Ashwini, Kelgonkar Prajakta, Jadhav Pratiksha...
Related Articles
Detection and Genotypic Characterization of High-Risk Human Papillomavirus Infec...
Sarjan Shah, Urmila Sureka, Shruti Jawale, Preeti Arora, Jagruti Karande...
An Assessment on Daily Work-Life Balance Among Parents with Autistic Children...
Drishya L., Shiju S. Dharan, Sani Anil, M. K. C. Nair, Arya B. Mohan...
Exploring the Experiences of Accredited Social Health Activists (ASHAs) in Imple...
Subhajit Giri, Sobhana Subhadarsini Purohit, Shamin Eabenson, Nitish Kumar Dhal, Adyasha Senapati...
One Condition, Seven Individuals: A Case Series on Individualized Homoeopathic M...
Parveen Middya, Sonali Priya, Mihir Kanti Biswas, Kausthab Dey, Apurba Pratihar...
More related articles
One Condition, Seven Individuals: A Case Series on Individualized Homoeopathic M...
Parveen Middya, Sonali Priya, Mihir Kanti Biswas, Kausthab Dey, Apurba Pratihar...
Multifunctional Polymeric Nanocarriers To Overcome Gastrointestinal Barriers in ...
P. Nanthagopal, R. Prethingadevi, G. Abirami, D. Nagavalli...